BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16700779)

  • 1. Current modalities and new advances in the treatment of basal cell carcinoma.
    Ceilley RI; Del Rosso JQ
    Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effective treatment of basal cell carcinoma.
    Skelton LA
    Br J Nurs; 2009 Mar 26-Apr 8; 18(6):346, 348-50. PubMed ID: 19329898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinoma: an evidence-based treatment update.
    Clark CM; Furniss M; Mackay-Wiggan JM
    Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
    Spencer JM
    Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Bahner JD; Bordeaux JS
    Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
    Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
    Tillman DK; Carroll MT
    J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s7-14. PubMed ID: 18277457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local reactions to imiquimod in the treatment of basal cell carcinoma.
    Tandon Y; Brodell RT
    Dermatol Online J; 2012 Sep; 18(9):1. PubMed ID: 23031368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
    Thissen MR; Kuijpers DI; Krekels GA
    J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
    Rigel DS; Torres AM; Ely H
    J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s15-6. PubMed ID: 18277458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large facial basal cell carcinoma treated with multimodal combination therapy.
    Rubenzik MK; Schwartz LR; Humphreys TR
    Cutis; 2011 Oct; 88(4):182-4. PubMed ID: 22106726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Management of Basal Cell Carcinoma.
    Tanese K
    Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy.
    Nakuçi M; Bassukas ID
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):35-8. PubMed ID: 23836356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
    Spencer JM; Tannenbaum A; Sloan L; Amonette RA
    Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basal cell carcinoma].
    Takenouchi T
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
    Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease.
    Goldenberg G; Hamid O
    J Drugs Dermatol; 2013 Dec; 12(12):1369-78. PubMed ID: 24301238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod: a review of basal cell carcinoma treatments.
    Karve SJ; Feldman SR; Yentzer BA; Pearce DJ; Balkrishnan R
    J Drugs Dermatol; 2008 Nov; 7(11):1044-51. PubMed ID: 19110735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
    Ruiz ES; Cohen JL; Friedman A
    J Drugs Dermatol; 2015 May; 14(5):450-2. PubMed ID: 25942661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.